Tapewire

Nasdaq · USD

PCVX

Vaxcyte, Inc.

Export transactions ↓
Tapewire entity
1164
SEC CIK
0001649094
Parsed reports
418

Last 12 months

Inside the activity.

0 purchase rows · 54 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202503
Jan 202600
Feb 202600
Mar 202605
Apr 202603
May 202601
Jun 2026016
Jul 2026011
Aug 202605
Sep 202606
Oct 202604

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 28, 2021 Filed May 29, 2021 00:18 UTC
PICKERING GRANTDirector · Chief Executive Officer
Exercise / conversionCommon Stock 2,656 $1.79 $4,754.24
Disclosure

SEC source: 0001209191-21-036710 · doc4.xml · nonDerivative · entry 3

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 582,910

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 27, 2021 Filed May 29, 2021 00:18 UTC
PICKERING GRANTDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 12,246 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-21-036710 · doc4.xml · derivative · entry 6

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 436,569

Underlying: Common Stock · 12,246 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
May 27, 2021 Filed May 29, 2021 00:18 UTC
PICKERING GRANTDirector · Chief Executive Officer
SaleCommon Stock 12,246 $22.10 $270,636.60
Disclosure

SEC source: 0001209191-21-036710 · doc4.xml · nonDerivative · entry 2

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,254

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $22.00 to $22.29. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 27, 2021 Filed May 29, 2021 00:18 UTC
PICKERING GRANTDirector · Chief Executive Officer
Exercise / conversionCommon Stock 12,246 $1.79 $21,920.34
Disclosure

SEC source: 0001209191-21-036710 · doc4.xml · nonDerivative · entry 1

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 592,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,563 shares acquired under the Employee Stock Purchase Plan on May 17, 2021.

Read SEC document
April 22, 2021 Filed Apr 23, 2021 19:31 UTC
Fairman JeffVP, Research
Exercise / conversionStock Option (right to buy) · Derivative 2,793 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-21-028190 · doc4.xml · derivative · entry 4

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,836

Underlying: Common Stock · 2,793 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 1/4 of the shares subject to the option vested on March 4, 2018, and 1/48th of the shares vest monthly thereafter.

Read SEC document
April 22, 2021 Filed Apr 23, 2021 19:31 UTC
Fairman JeffVP, Research
Exercise / conversionCommon Stock 2,793 $1.79 $4,999.47
Disclosure

SEC source: 0001209191-21-028190 · doc4.xml · nonDerivative · entry 1

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,201

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 05, 2021 Filed Apr 7, 2021 21:17 UTC
Sauer PaulSVP Process Dev, Manufacturing
OtherStock Option (right to buy) · Derivative 7,611 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0001209191-21-025999 · doc4.xml · derivative · entry 5

Sauer Paul · CIK 0001813796 · SVP Process Dev, Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,027

Underlying: Common Stock · 7,611 shares

Expires 2029-03-20

F1 · kind: Transfer of shares and the reporting person's economic interest in stock options (right to buy) to reporting person's spouse pursuant to a property settlement agreement in connection with separation proceedings. While the reporting person will retain the options, the reporting person's spouse will receive the economic benefit from, and has sole discretion with respect to, the portion of the options representing the spouse's transferred economic interest, including exercises thereof and sales of shares underlying such portion. Accordingly, the reporting person will not report beneficial ownership of or dispositions of the portion of such options representing the spouse's transferred economic interest, nor will the reporting person report beneficial ownership of or acquisitions or dispositions of the underlying shares, in future Section 16(a) filings.

F4 · derivative.exercise_date: As of the date of transfer, the shares subject to the option representing the reporting person's remaining economic interest will vest in monthly installments with respect to 617 shares from May 1, 2021 to January 1, 2023.

Read SEC document
April 05, 2021 Filed Apr 7, 2021 21:17 UTC
Sauer PaulSVP Process Dev, Manufacturing
OtherStock Option (right to buy) · Derivative 21,871 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0001209191-21-025999 · doc4.xml · derivative · entry 4

Sauer Paul · CIK 0001813796 · SVP Process Dev, Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,197

Underlying: Common Stock · 21,871 shares

Expires 2028-07-23

F1 · kind: Transfer of shares and the reporting person's economic interest in stock options (right to buy) to reporting person's spouse pursuant to a property settlement agreement in connection with separation proceedings. While the reporting person will retain the options, the reporting person's spouse will receive the economic benefit from, and has sole discretion with respect to, the portion of the options representing the spouse's transferred economic interest, including exercises thereof and sales of shares underlying such portion. Accordingly, the reporting person will not report beneficial ownership of or dispositions of the portion of such options representing the spouse's transferred economic interest, nor will the reporting person report beneficial ownership of or acquisitions or dispositions of the underlying shares, in future Section 16(a) filings.

F3 · derivative.exercise_date: As of the date of transfer, the shares subject to the option representing the reporting person's remaining economic interest will vest in monthly installments with respect to 1,459 shares from April 24, 2021 to July 24, 2022.

Read SEC document
April 05, 2021 Filed Apr 7, 2021 21:17 UTC
Sauer PaulSVP Process Dev, Manufacturing
OtherStock Option (right to buy) · Derivative 14,253 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-21-025999 · doc4.xml · derivative · entry 3

Sauer Paul · CIK 0001813796 · SVP Process Dev, Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,173

Underlying: Common Stock · 14,253 shares

Expires 2027-05-17

F1 · kind: Transfer of shares and the reporting person's economic interest in stock options (right to buy) to reporting person's spouse pursuant to a property settlement agreement in connection with separation proceedings. While the reporting person will retain the options, the reporting person's spouse will receive the economic benefit from, and has sole discretion with respect to, the portion of the options representing the spouse's transferred economic interest, including exercises thereof and sales of shares underlying such portion. Accordingly, the reporting person will not report beneficial ownership of or dispositions of the portion of such options representing the spouse's transferred economic interest, nor will the reporting person report beneficial ownership of or acquisitions or dispositions of the underlying shares, in future Section 16(a) filings.

F2 · derivative.exercise_date: The shares subject to the option representing the reporting person's remaining economic interest are fully vested and exercisable.

Read SEC document
April 05, 2021 Filed Apr 7, 2021 21:17 UTC
Sauer PaulSVP Process Dev, Manufacturing
OtherStock Option (right to buy) · Derivative 4,168 $0.00 Strike: $0.80 $0.00
Disclosure

SEC source: 0001209191-21-025999 · doc4.xml · derivative · entry 2

Sauer Paul · CIK 0001813796 · SVP Process Dev, Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,168

Underlying: Common Stock · 4,168 shares

Expires 2026-04-19

F1 · kind: Transfer of shares and the reporting person's economic interest in stock options (right to buy) to reporting person's spouse pursuant to a property settlement agreement in connection with separation proceedings. While the reporting person will retain the options, the reporting person's spouse will receive the economic benefit from, and has sole discretion with respect to, the portion of the options representing the spouse's transferred economic interest, including exercises thereof and sales of shares underlying such portion. Accordingly, the reporting person will not report beneficial ownership of or dispositions of the portion of such options representing the spouse's transferred economic interest, nor will the reporting person report beneficial ownership of or acquisitions or dispositions of the underlying shares, in future Section 16(a) filings.

F2 · derivative.exercise_date: The shares subject to the option representing the reporting person's remaining economic interest are fully vested and exercisable.

Read SEC document
April 05, 2021 Filed Apr 7, 2021 21:17 UTC
Sauer PaulSVP Process Dev, Manufacturing
OtherCommon Stock 38,308 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-025999 · doc4.xml · nonDerivative · entry 1

Sauer Paul · CIK 0001813796 · SVP Process Dev, Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,591

F1 · kind: Transfer of shares and the reporting person's economic interest in stock options (right to buy) to reporting person's spouse pursuant to a property settlement agreement in connection with separation proceedings. While the reporting person will retain the options, the reporting person's spouse will receive the economic benefit from, and has sole discretion with respect to, the portion of the options representing the spouse's transferred economic interest, including exercises thereof and sales of shares underlying such portion. Accordingly, the reporting person will not report beneficial ownership of or dispositions of the portion of such options representing the spouse's transferred economic interest, nor will the reporting person report beneficial ownership of or acquisitions or dispositions of the underlying shares, in future Section 16(a) filings.

Read SEC document
April 01, 2021 Filed Apr 6, 2021 20:06 UTC
Sauer PaulSVP Process Dev, Manufacturing
GrantStock Option (right to buy) · Derivative 40,000 $0.00 Strike: $20.93 $0.00
Disclosure

SEC source: 0001209191-21-025761 · doc4.xml · derivative · entry 1

Sauer Paul · CIK 0001813796 · SVP Process Dev, Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-03-31

F1 · derivative.exercise_date: 1/48 of shares subject to the option vest on May 1, 2021, and 1/48 of the shares vest monthly thereafter.

Read SEC document
April 01, 2021 Filed Apr 6, 2021 20:10 UTC
Fairman JeffVP, Research
GrantStock Option (right to buy) · Derivative 40,000 $0.00 Strike: $20.93 $0.00
Disclosure

SEC source: 0001209191-21-025763 · doc4.xml · derivative · entry 1

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-03-31

F1 · derivative.exercise_date: 1/48 of shares subject to the option vest on May 1, 2021, and 1/48 of the shares vest monthly thereafter.

Read SEC document
April 01, 2021 Filed Apr 7, 2021 00:04 UTC
Wassil JimChief Operating Officer
GrantStock Option (right to buy) · Derivative 93,340 $0.00 Strike: $20.93 $0.00
Disclosure

SEC source: 0001209191-21-025760 · doc4.xml · derivative · entry 1

Wassil Jim · CIK 0001813798 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,340

Underlying: Common Stock · 93,340 shares

Expires 2031-03-31

F1 · derivative.exercise_date: 1/48 of shares subject to the option vest on May 1, 2021, and 1/48 of the shares vest monthly thereafter.

Read SEC document
April 01, 2021 Filed Apr 7, 2021 00:08 UTC
Wright-Mitchell JaneGeneral Counsel
GrantStock Option (right to buy) · Derivative 93,340 $0.00 Strike: $20.93 $0.00
Disclosure

SEC source: 0001209191-21-025762 · doc4.xml · derivative · entry 1

Wright-Mitchell Jane · CIK 0001614568 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,340

Underlying: Common Stock · 93,340 shares

Expires 2031-03-31

F1 · derivative.exercise_date: 1/48 of shares subject to the option vest on May 1, 2021, and 1/48 of the shares vest monthly thereafter.

Read SEC document
April 01, 2021 Filed Apr 7, 2021 00:02 UTC
GUGGENHIME ANDREWPresident and CFO
GrantStock Option (right to buy) · Derivative 145,000 $0.00 Strike: $20.93 $0.00
Disclosure

SEC source: 0001209191-21-025759 · doc4.xml · derivative · entry 1

GUGGENHIME ANDREW · CIK 0001230724 · President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,000

Underlying: Common Stock · 145,000 shares

Expires 2031-03-31

F1 · derivative.exercise_date: 1/48 of shares subject to the option vest on May 1, 2021, and 1/48 of the shares vest monthly thereafter.

Read SEC document
April 01, 2021 Filed Apr 7, 2021 00:01 UTC
PICKERING GRANTDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 310,000 $0.00 Strike: $20.93 $0.00
Disclosure

SEC source: 0001209191-21-025758 · doc4.xml · derivative · entry 1

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 310,000

Underlying: Common Stock · 310,000 shares

Expires 2031-03-31

F1 · derivative.exercise_date: 1/48 of shares subject to the option vest on May 1, 2021, and 1/48 of the shares vest monthly thereafter.

Read SEC document
March 26, 2021 Filed Mar 29, 2021 19:18 UTC
Fairman JeffVP, Research
Exercise / conversionStock Option (right to buy) · Derivative 4,750 $0.00 Strike: $0.04 $0.00
Disclosure

SEC source: 0001209191-21-023482 · doc4.xml · derivative · entry 6

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,259

Underlying: Common Stock · 4,750 shares

Expires 2025-04-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
March 26, 2021 Filed Mar 29, 2021 19:18 UTC
Fairman JeffVP, Research
SaleCommon Stock 1,361 $24.48 $33,317.28
Disclosure

SEC source: 0001209191-21-023482 · doc4.xml · nonDerivative · entry 3

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,408

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $24.15 to $24.77. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
March 26, 2021 Filed Mar 29, 2021 19:18 UTC
Fairman JeffVP, Research
SaleCommon Stock 3,389 $23.64 $80,115.96
Disclosure

SEC source: 0001209191-21-023482 · doc4.xml · nonDerivative · entry 2

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,769

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $23.125 to $24.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
March 26, 2021 Filed Mar 29, 2021 19:18 UTC
Fairman JeffVP, Research
Exercise / conversionCommon Stock 4,750 $0.04 $190.00
Disclosure

SEC source: 0001209191-21-023482 · doc4.xml · nonDerivative · entry 1

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 19, 2021 Filed Mar 24, 2021 00:49 UTC
PICKERING GRANTDirector · President & CEO
Exercise / conversionStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-21-022757 · doc4.xml · derivative · entry 4

PICKERING GRANT · CIK 0001258693 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 448,815

Underlying: Common Stock · 15,000 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/4 of the shares subject to the option vested on March 4, 2018, and 1/48 of the shares vest monthly thereafter.

Read SEC document
March 19, 2021 Filed Mar 24, 2021 00:49 UTC
PICKERING GRANTDirector · President & CEO
SaleCommon Stock 15,000 $25.77 $386,550.00
Disclosure

SEC source: 0001209191-21-022757 · doc4.xml · nonDerivative · entry 2

PICKERING GRANT · CIK 0001258693 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 578,691

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $25.26 to $26.13. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
March 19, 2021 Filed Mar 24, 2021 00:49 UTC
PICKERING GRANTDirector · President & CEO
Exercise / conversionCommon Stock 15,000 $1.79 $26,850.00
Disclosure

SEC source: 0001209191-21-022757 · doc4.xml · nonDerivative · entry 1

PICKERING GRANT · CIK 0001258693 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 593,691

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2021 Filed Mar 17, 2021 20:55 UTC
Wright-Mitchell JaneGeneral Counsel
Exercise / conversionStock Option (right to buy) · Derivative 2,500 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0001209191-21-021392 · doc4.xml · derivative · entry 4

Wright-Mitchell Jane · CIK 0001614568 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,968

Underlying: Common Stock · 2,500 shares

Expires 2029-03-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter.

Read SEC document
March 15, 2021 Filed Mar 17, 2021 20:55 UTC
Wright-Mitchell JaneGeneral Counsel
SaleCommon Stock 1,487 $27.49 $40,877.63
Disclosure

SEC source: 0001209191-21-021392 · doc4.xml · nonDerivative · entry 3

Wright-Mitchell Jane · CIK 0001614568 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,562

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $27.355 to $27.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
March 15, 2021 Filed Mar 17, 2021 20:55 UTC
Wright-Mitchell JaneGeneral Counsel
SaleCommon Stock 1,013 $27.01 $27,361.13
Disclosure

SEC source: 0001209191-21-021392 · doc4.xml · nonDerivative · entry 2

Wright-Mitchell Jane · CIK 0001614568 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,049

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $26.28 to $27.27. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
March 15, 2021 Filed Mar 17, 2021 20:55 UTC
Wright-Mitchell JaneGeneral Counsel
Exercise / conversionCommon Stock 2,500 $2.03 $5,075.00
Disclosure

SEC source: 0001209191-21-021392 · doc4.xml · nonDerivative · entry 1

Wright-Mitchell Jane · CIK 0001614568 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,062

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2021 Filed Mar 15, 2021 16:29 UTC
Sauer PaulSVP Process Dev, Manufacturing
Exercise / conversionStock Option (right to buy) · Derivative 2,500 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-21-020468 · doc4.xml · derivative · entry 3

Sauer Paul · CIK 0001813796 · SVP Process Dev, Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,426

Underlying: Common Stock · 2,500 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/4 of the shares subject to the option vested on March 4, 2018, and 1/48 of the shares vest monthly thereafter.

Read SEC document
March 11, 2021 Filed Mar 15, 2021 16:29 UTC
Sauer PaulSVP Process Dev, Manufacturing
SaleCommon Stock 2,500 $25.00 $62,500.00
Disclosure

SEC source: 0001209191-21-020468 · doc4.xml · nonDerivative · entry 2

Sauer Paul · CIK 0001813796 · SVP Process Dev, Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,899

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 11, 2021 Filed Mar 15, 2021 16:29 UTC
Sauer PaulSVP Process Dev, Manufacturing
Exercise / conversionCommon Stock 2,500 $1.79 $4,475.00
Disclosure

SEC source: 0001209191-21-020468 · doc4.xml · nonDerivative · entry 1

Sauer Paul · CIK 0001813796 · SVP Process Dev, Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,399

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 17:37 UTC
Fairman JeffVP, Research
Exercise / conversionStock Option (right to buy) · Derivative 4,750 $0.00 Strike: $0.04 $0.00
Disclosure

SEC source: 0001209191-21-016339 · doc4.xml · derivative · entry 7

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,009

Underlying: Common Stock · 4,750 shares

Expires 2025-04-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 17:37 UTC
Fairman JeffVP, Research
SaleCommon Stock 68 $25.33 $1,722.44
Disclosure

SEC source: 0001209191-21-016339 · doc4.xml · nonDerivative · entry 4

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,408

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $25.23 to $25.41. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 17:37 UTC
Fairman JeffVP, Research
SaleCommon Stock 1,372 $24.34 $33,394.48
Disclosure

SEC source: 0001209191-21-016339 · doc4.xml · nonDerivative · entry 3

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,476

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $24.13 to $24.94. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 17:37 UTC
Fairman JeffVP, Research
SaleCommon Stock 3,310 $23.73 $78,546.30
Disclosure

SEC source: 0001209191-21-016339 · doc4.xml · nonDerivative · entry 2

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,848

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $23.08 to $24.075. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 17:37 UTC
Fairman JeffVP, Research
Exercise / conversionCommon Stock 4,750 $0.04 $190.00
Disclosure

SEC source: 0001209191-21-016339 · doc4.xml · nonDerivative · entry 1

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 21:25 UTC
Wassil JimChief Operating Officer
Exercise / conversionStock Option (right to buy) · Derivative 3,000 $0.00 Strike: $2.42 $0.00
Disclosure

SEC source: 0001209191-21-013791 · doc4.xml · derivative · entry 4

Wassil Jim · CIK 0001813798 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 245,926

Underlying: Common Stock · 3,000 shares

Expires 2029-12-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 21:25 UTC
Wassil JimChief Operating Officer
SaleCommon Stock 1,801 $26.99 $48,608.99
Disclosure

SEC source: 0001209191-21-013791 · doc4.xml · nonDerivative · entry 3

Wassil Jim · CIK 0001813798 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,381

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $26.745 to $27.305. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 21:25 UTC
Wassil JimChief Operating Officer
SaleCommon Stock 1,199 $26.43 $31,689.57
Disclosure

SEC source: 0001209191-21-013791 · doc4.xml · nonDerivative · entry 2

Wassil Jim · CIK 0001813798 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,182

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $25.70 to $26.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 21:25 UTC
Wassil JimChief Operating Officer
Exercise / conversionCommon Stock 3,000 $2.42 $7,260.00
Disclosure

SEC source: 0001209191-21-013791 · doc4.xml · nonDerivative · entry 1

Wassil Jim · CIK 0001813798 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,381

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 21:23 UTC
PICKERING GRANTDirector · President & CEO
Exercise / conversionStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-21-013782 · doc4.xml · derivative · entry 5

PICKERING GRANT · CIK 0001258693 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 463,815

Underlying: Common Stock · 15,000 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 1/4 of the shares subject to the option vested on March 4, 2018, and 1/48 of the shares vest monthly thereafter.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 21:23 UTC
PICKERING GRANTDirector · President & CEO
SaleCommon Stock 6,636 $26.72 $177,313.92
Disclosure

SEC source: 0001209191-21-013782 · doc4.xml · nonDerivative · entry 3

PICKERING GRANT · CIK 0001258693 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 578,691

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $26.61 to $26.97. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 21:23 UTC
PICKERING GRANTDirector · President & CEO
SaleCommon Stock 8,364 $26.27 $219,722.28
Disclosure

SEC source: 0001209191-21-013782 · doc4.xml · nonDerivative · entry 2

PICKERING GRANT · CIK 0001258693 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 585,327

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $25.605 to $26.60. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 21:23 UTC
PICKERING GRANTDirector · President & CEO
Exercise / conversionCommon Stock 15,000 $1.79 $26,850.00
Disclosure

SEC source: 0001209191-21-013782 · doc4.xml · nonDerivative · entry 1

PICKERING GRANT · CIK 0001258693 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 593,691

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2021 Filed Feb 17, 2021 21:55 UTC
Wright-Mitchell JaneGeneral Counsel
Exercise / conversionStock Option (right to buy) · Derivative 2,500 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0001209191-21-011322 · doc4.xml · derivative · entry 3

Wright-Mitchell Jane · CIK 0001614568 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,468

Underlying: Common Stock · 2,500 shares

Expires 2029-03-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter.

Read SEC document
February 16, 2021 Filed Feb 17, 2021 21:55 UTC
Wright-Mitchell JaneGeneral Counsel
SaleCommon Stock 2,500 $26.95 $67,375.00
Disclosure

SEC source: 0001209191-21-011322 · doc4.xml · nonDerivative · entry 2

Wright-Mitchell Jane · CIK 0001614568 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,562

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $26.52 to $27.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 16, 2021 Filed Feb 17, 2021 21:55 UTC
Wright-Mitchell JaneGeneral Counsel
Exercise / conversionCommon Stock 2,500 $2.03 $5,075.00
Disclosure

SEC source: 0001209191-21-011322 · doc4.xml · nonDerivative · entry 1

Wright-Mitchell Jane · CIK 0001614568 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,062

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 11, 2021 Filed Feb 16, 2021 19:46 UTC
Sauer PaulSVP Process Dev, Manufacturing
Exercise / conversionStock Option (right to buy) · Derivative 2,500 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-21-011013 · doc4.xml · derivative · entry 4

Sauer Paul · CIK 0001813796 · SVP Process Dev, Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,926

Underlying: Common Stock · 2,500 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 1/4 of the shares subject to the option vested on March 4, 2018, and 1/48 of the shares vest monthly thereafter.

Read SEC document
February 11, 2021 Filed Feb 16, 2021 19:46 UTC
Sauer PaulSVP Process Dev, Manufacturing
SaleCommon Stock 316 $27.27 $8,617.32
Disclosure

SEC source: 0001209191-21-011013 · doc4.xml · nonDerivative · entry 3

Sauer Paul · CIK 0001813796 · SVP Process Dev, Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,899

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $27.22 to $27.315. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 11, 2021 Filed Feb 16, 2021 19:46 UTC
Sauer PaulSVP Process Dev, Manufacturing
SaleCommon Stock 2,184 $26.56 $58,007.04
Disclosure

SEC source: 0001209191-21-011013 · doc4.xml · nonDerivative · entry 2

Sauer Paul · CIK 0001813796 · SVP Process Dev, Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,215

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $25.97 to $26.96. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.